Assertio Holdings to Report Q4 and Full Year 2025 Earnings

The pharmaceutical company will release its latest financial results on March 12th.

Mar. 3, 2026 at 10:05pm

Got story updates? Submit your updates here. ›

Assertio Holdings, Inc., a pharmaceutical company, announced that it will report its fourth quarter and full year 2025 financial results on March 12, 2026. The company, based in Lake Forest, Illinois, did not provide any additional details about the upcoming earnings release.

Why it matters

As a public company, Assertio Holdings' quarterly and annual financial results are closely watched by investors to gauge the overall performance and health of the business. The upcoming report will provide insights into the company's operations, sales, and profitability over the past year.

The details

Assertio Holdings, Inc. is a pharmaceutical company that develops and commercializes specialty products to treat central nervous system disorders, pain, and inflammatory diseases. The company did not disclose any specifics about what it expects to report for the fourth quarter and full year 2025.

  • Assertio Holdings will report its Q4 and full year 2025 financial results on March 12, 2026.

The players

Assertio Holdings, Inc.

A pharmaceutical company that develops and commercializes specialty products to treat central nervous system disorders, pain, and inflammatory diseases.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be closely watching Assertio Holdings' upcoming earnings report for signs of the company's financial performance and outlook for the year ahead.

The takeaway

Assertio Holdings' Q4 and full year 2025 earnings report will provide important financial data and insights into the pharmaceutical company's operations and future prospects.